Glenmark Launches Nitric Oxide Nasal Spray in India for Treatment of Adult Covid Patients

Phase 3 trial in India met the key endpoints and demonstrated reduction of viral load of 94% in 24 hours and 99% in 48 hours.

from Top India News- News18.com https://ift.tt/vtZF8Xn